Wednesday, February 10, 2010, 7:30am EST - Canadian Markets open in 2 hours.
To create a watchlist or portfolio of shares, Sign-in or Register

Celera Group (CRA)

 On Feb 9: 6.58 USD   0.00 (0.00%)  
MORE ON CRA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Celera Corporation (NasdaqNM:CRA) Delayed quote dataEdit
Last Trade: 6.58 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 6.58
Open: N/A
Bid: N/A
Ask: 7.05 x 400
1y Target Est: 19.00
Day's Range: N/A - N/A
52wk Range: 5.03 - 10.14
Volume: 0
Avg Vol (3m): 535,575
Market Cap: 539.18M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A%)
Celera Group (CRA)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add CRA to Portfolio   Download Data

HEADLINES
• [$$] Biotech ETFs Are Looking Healthy
at RealMoney by TheStreet.com (Mon, Feb 8)
• 5 Diagnostics Stocks Get 2010 Buy Rating From Natixis Bleichroeder Expert Industry Analyst
Wall Street Transcript (Mon, Jan 25)
• Small Cap Value and Earnings Surprises Portfolio
at Seeking Alpha (Mon, Jan 18)
• [$$] 13D Filings
at Barrons.com (Sat, Jan 16)
• Celera Grants a License to the University of California, San Francisco for the Development of KIF6 Testing
Business Wire (Tue, Jan 12)
• Celera to Webcast Presentation at JPMorgan Healthcare Conference
Business Wire (Tue, Jan 5)
• Combining Value and Earnings Surprises for Outsize Returns
at Seeking Alpha (Mon, Dec 21)
• 5-Star Stocks on the Upswing
at Motley Fool (Fri, Dec 11)
• Tech Rights Give Companies Upper Hand
at TheStreet.com (Tue, Dec 8)
• 9 Things You Should Do Instead of Buying Stocks
at Motley Fool (Wed, Nov 18)
• CELERA CORP Financials
EDGAR Online Financials (Fri, Nov 13)
• CELERA CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
More Headlines for CRA...
ANALYST
EPS Est (next year) (Jun-08) : 0.04
EPS Est (in 2 years) (Jun-09) : 0.19
Avg Rec (current)*: 2.2
PEG Ratio: 25.75
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Celera Group, a molecular diagnostics business, engages in the identification and validation of diagnostic markers using proprietary genomics and proteomics discovery platforms.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices